Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study

<p><strong>Background</strong><br> Post-authorisation vaccine safety surveillance is well established for reporting common adverse events of interest (AEIs) following influenza vaccines, but not for COVID-19 vaccines.</p> <p><strong>Aim</strong><br...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Tsang, RSM, Joy, M, Byford, R, Robertson, C, Anand, SN, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, DT, Murphy, S, O'Reilly, D, Owen, RK, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Hobbs, FDR, de Lusignan, S
Format:	Journal article
Język:	English
Wydane:	European Centre for Disease Prevention and Control 2023

Podobne zapisy

Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study
od: Tsang, RS, i wsp.
Wydane: (2023)

Investigating the association between COVID-19 vaccination and care home outbreak frequency and duration
od: Bradley, DT, i wsp.
Wydane: (2021)

Adverse events of interest following influenza vaccination, a comparison of cell culture-based with egg-based alternatives: English sentinel network annual report paper 2019/20
od: de Lusignan, S, i wsp.
Wydane: (2021)

Variations in COVID-19 vaccination uptake among people in receipt of psychotropic drugs: cross-sectional analysis of a national population-based prospective cohort
od: Murphy, S, i wsp.
Wydane: (2022)

A targeted approach to vaccine hesitancy
od: Leston, M, i wsp.
Wydane: (2023)

Methodological issues in using a common data model of COVID-19 vaccine uptake and important adverse events of interest: feasibility study of data and connectivity COVID-19 vaccines pharmacovigilance in the United Kingdom
od: Delanerolle, G, i wsp.
Wydane: (2022)

National rates and disparities in childhood vaccination and vaccine-preventable disease during the COVID-19 pandemic: English sentinel network retrospective database study
od: Hoang, U, i wsp.
Wydane: (2022)

Adverse events of interest following influenza vaccination in the first season of adjuvanted trivalent immunization: retrospective cohort study
od: de Lusignan, S, i wsp.
Wydane: (2022)

Future reporting of vaccine uptake needs to include any change in ethnic or socioeconomic disparities
od: Hoang, U, i wsp.
Wydane: (2022)

Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England
od: Ward, IL, i wsp.
Wydane: (2024)

COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales
od: Gu, X, i wsp.
Wydane: (2024)

Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
od: Simpson, CR, i wsp.
Wydane: (2022)

Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales
od: Torabi, F, i wsp.
Wydane: (2022)

Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups
od: Whitaker, HJ, i wsp.
Wydane: (2022)

COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
od: Agrawal, U, i wsp.
Wydane: (2021)

Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United Kingdom
od: Gayathri Delanerolle, i wsp.
Wydane: (2022-08-01)

Waning of first and second dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales
od: Kerr, S, i wsp.
Wydane: (2022)

Acknowledgment to reviewers—October 2019 to September 2020
Wydane: (2020-12-01)

Lahars on Atlasov Island in September-October 2022 (Kuril Islands)
od: Kotenko T.A.
Wydane: (2022-12-01)

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
od: Simpson, CR, i wsp.
Wydane: (2021)

Report of the WHO technical consulatation on the effects of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30 - October 1, 2015
od: Fell, D, i wsp.
Wydane: (2017)

Human vaccines and immunotherapeutics: News October 2024
od: Ronald Ellis, i wsp.
Wydane: (2024-12-01)

Human vaccines & immunotherapeutics: news October 2021
Wydane: (2022-01-01)

Human vaccines & immunotherapeutics: News October 2022
od: Ronald Ellis, i wsp.
Wydane: (2022-11-01)

Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study
od: Tsang, RSM, i wsp.
Wydane: (2023)

COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: a national prospective cohort study
od: Bedston, S, i wsp.
Wydane: (2023)

Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019
od: Brandon J. Patterson, i wsp.
Wydane: (2021-08-01)

Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales
od: Bedston, S, i wsp.
Wydane: (2023)

Ice conditions of navigation during the NABOS-2021 expedition in September-October 2021
od: Timofeeva A.B.
Wydane: (2021-12-01)

Human vaccines and immunotherapeutics: News September 2024
od: Ronald Ellis, i wsp.
Wydane: (2024-12-01)

Human vaccines and immunotherapeutics: News September 2023
od: Ronald Ellis, i wsp.
Wydane: (2023-12-01)

Human vaccines & immunotherapeutics: news September 2021
Wydane: (2022-01-01)

Human vaccines & immunotherapeutics: News September 2022
od: Ronald Ellis, i wsp.
Wydane: (2022-11-01)

Editorial for September/October Issue of AACE Clinical Case Reports
od: Sina Jasim, MD, MPH
Wydane: (2024-09-01)

Editorial for September/October Issue of AACE Clinical Case Reports
od: Sina Jasim, MD, MPH
Wydane: (2023-09-01)

The Role of Aviation in the Malgobek Defensive Operations (September-October 1942)
od: Matiev Timur Kh.
Wydane: (2016-09-01)

Editorial for September/October Issue of AACE Clinical Case Reports
od: Sina Jasim, MD, MPH
Wydane: (2022-09-01)

Editorial for September/October Issue of AACE Clinical Case Reports
od: Sina Jasim, MD, MPH
Wydane: (2021-09-01)

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
od: Agrawal, U, i wsp.
Wydane: (2022)

Hepatitis A Vaccination Coverage Among People With Chronic Liver Disease in England (HEALD): Protocol for a Retrospective Cohort Study
od: Bernardo Meza-Torres, i wsp.
Wydane: (2023-10-01)